Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens - Wikidata - wikimedia - TriplyDB

Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens

Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens

http://www.wikidata.org/entity/Q28607716

about

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events Transgender women, hormonal therapy and HIV treatment: a comprehensive review of the literature and recommendations for best practices New evidence for cardiac benefit of postmenopausal hormone therapy.Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.Prevention and treatment of venous thromboembolism during HRT: current perspectives.A Reappraisal of Women's Health Initiative Estrogen-Alone Trial: Long-Term Outcomes in Women 50-59 Years of Age.Menopausal hormone therapy and venous thromboembolism.Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study.Hormone replacement therapy and risk of atrial fibrillation in Taiwanese menopause women: A nationwide cohort study Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers Estrogen and the female heart.Hormones and venous thromboembolism among postmenopausal women.Hormone replacement therapy in the treatment of perimenopausal depression.The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.Safety and benefit considerations for menopausal hormone therapy.Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.Cross-sectional association of endogenous steroid hormone, sex hormone-binding globulin, and precursor steroid levels with hemostatic factor levels in postmenopausal women.Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.

P2860

Q26751149-D6453768-5C53-426B-9218-977FFC6314BA Q26822460-576F8C50-4CF0-460E-9537-757DF989B9E8 Q28067469-08AD39DC-75CB-4A5B-8493-317C18DF1CAF Q30396979-A085D755-44F1-444F-B2BB-60C048C3279F Q30841046-FADE8E86-9CD3-4B92-BD35-19A1415F9826 Q34140721-89B5B39E-77F3-4B2B-AFBF-8D02072E37D4 Q35035445-FDC5B3D1-A45A-4890-9651-910EABB54849 Q35903637-8550DEE7-C498-44A8-BD83-E826A2D083B4 Q36515384-1C38287A-76CB-4EBD-8552-E81A4D38B34F Q36774462-06FDCFB8-69EA-4F59-9CB1-4D565D296708 Q37727617-5913E0AE-1CA3-4E2E-83B3-BB58701A9415 Q38181814-AE72FCF1-93DF-4A65-A917-68FFB9483DE5 Q38249888-A8FB0235-DC78-44FB-BD44-FD285B626E62 Q38259467-3F6EB8DF-ADC4-47B9-910F-532EB7C0D6F3 Q38611601-D224E761-DB99-46CF-AF5C-63AE50AB2A5C Q38700757-4B9423A9-9ACC-4239-8AF7-313FF2E9D9A1 Q38986410-655F9B90-7F24-49EE-AF3A-0D70E55D255E Q40503693-5B8BF4B3-5A3D-40AD-9704-95DD068B1BF2 Q46066644-846B33CD-C17F-4848-87F3-67DB39129E5B

P2860

Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens

http://www.wikidata.org/entity/Q28607716

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@ast

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@en

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@nl

type

label

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@ast

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@en

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@nl

prefLabel

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@ast

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@en

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@nl

P1433

Q28607716-1CEA9596-5019-4DBA-9F48-AAACE8CEEE1C

P1476

Q28607716-BB7138ED-0600-4F06-AB3F-B8CB5F264551

P2093

Q28607716-0298F26F-D2B8-4987-9F21-75D5937F3CBD

Q28607716-1DD62222-8B9D-46CE-81AC-BBDC8A3673CE

Q28607716-21A6AD30-63E6-4934-9B38-861D7A6A537D

Q28607716-2CE1765C-5C13-41B6-80E4-AC34A10201EC

Q28607716-4601EE40-15D3-4FD3-B9AE-FC50F3AE67CA

Q28607716-77C6BE45-BB97-48E3-92BF-DEB142F0D8D1

Q28607716-A8385DEB-B5F8-48AF-A874-7D1CBD0FB1C2

Q28607716-AEC9AEFD-7E25-4EC8-B36D-18769708AB68

Q28607716-B40338F5-C413-4C6C-A8DC-802447993090

Q28607716-BB6F14F0-B549-44E4-BE30-D3CCACF40E31

P2860

Q28607716-01CB1657-75C7-4908-8F41-78897FABC060

Q28607716-0562F0ED-8674-43EF-94EA-974C7BFE86ED

Q28607716-0869B41E-02EF-47F0-825D-1650F6E18ACF

Q28607716-28C137D3-7D47-4029-9207-F53EA7D4B71C

Q28607716-2C93E9CF-24CE-4A5B-A414-4E0523EE7465

Q28607716-464CF7FD-28D8-4BFE-A73E-F75CA4A62FAB

Q28607716-51BCCAEB-D2BE-4A32-997A-CBA9259A8CF6

Q28607716-58D5A158-82E0-4645-9E43-52FFB12F3E29

Q28607716-72621BE6-13C0-4FAA-B7DE-7A8F602F5E09

Q28607716-72FB9D24-05A5-4866-BB6F-95653E983915

P304

Q28607716-530DE3E1-D498-4D2E-8025-261E3B24BFFB

P31

Q28607716-279DE595-82E2-4404-BBB8-B23A5BE320B8

P3181

Q28607716-207CF791-419E-4E92-BEFD-9BB93E6A2228

P356

Q28607716-2B04EC37-0029-404A-AF0C-07D7A01CAF2C

P407

Q28607716-B77D2CEC-0C10-4ABB-B04E-2977F9097103

P433

Q28607716-25D25609-81B7-498D-BB79-F8DC237242FF

P478

Q28607716-8FBBFF7C-8803-4012-A94B-B93302B47467

P50

Q28607716-231E6387-ADF0-423B-9022-F6DCB2E69451

Q28607716-4E470A3C-FB55-4BEE-B214-3F65925AE793

Q28607716-6C3FCB49-2ADF-4DAC-AF17-0ABA7D737D35

P577

Q28607716-7B442856-EC2D-4396-A77D-821EB1350522

P698

Q28607716-51507026-1EDF-45FA-ADF0-0B5DBD40C5A8

P921

Q28607716-52EF6D0B-DB59-4FD3-A424-69BB17D89BEA

P932

Q28607716-9F53EA35-1614-4FB3-9C19-7F34DBE2A9B8

P3181

P356

JAMAINTERNMED.2013.11074

P1433

JAMA Internal Medicine

P1476

Lower risk of cardiovascular e ...... al conjugated equine estrogens

@en

P2093

Astrid van Hylckama Vlieg

http://www.w3.org/2001/XMLSchema#string

Barbara McKnight

http://www.w3.org/2001/XMLSchema#string

Frits R Rosendaal

http://www.w3.org/2001/XMLSchema#string

James S Floyd

http://www.w3.org/2001/XMLSchema#string

Kenneth M Rice

http://www.w3.org/2001/XMLSchema#string

Kerri L Wiggins

http://www.w3.org/2001/XMLSchema#string

Laura B Harrington

http://www.w3.org/2001/XMLSchema#string

Marc Blondon

http://www.w3.org/2001/XMLSchema#string

Melody Hwang

http://www.w3.org/2001/XMLSchema#string

Nicholas L Smith

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

Pharmacokinetic and pharmacologic variation between different estrogen products

Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

The pharmacokinetics and efficacy of different estrogens are not equivalent.

Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review.

Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

Hormone therapy prescribing patterns in the United States.

P304

25-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2422477

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMAINTERNMED.2013.11074

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

Susan R Heckbert

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24081194

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

4636198

http://www.w3.org/2001/XMLSchema#string